Literature DB >> 3148681

Simplified turbidimetric determination of apolipoproteins A-I, A-II and B using a microtitre method.

M Sandkamp1, B Tambyrajah, H Schriewer, G Assmann.   

Abstract

A turbidimetric method is described for the determination of apolipoproteins A-I, A-II and B on microtitre plates. Regression analysis of the resulting values showed a good correlation to apolipoprotein values determined turbidimetrically on Cobas Bio (apolipoprotein A-I, A-II), and those determined by means of radial immuno diffusion (RID) (apolipoprotein A-I: r = 0.93, y = 1.02 x - 5.0, n = 63; apolipoprotein A-II: r = 0.90, y = 1.07 x - 5.6, n = 44; apolipoprotein B: r = 0.92, y = 0.95 x + 9.0, n = 58). The variation coefficient in the series was 3.5% (apolipoprotein A-I, n = 21), 2.5% (apolipoprotein A-II, n = 20) and 3.6% (apolipoprotein B, n = 19); and the variation coefficient from day to day 3.1% (apolipoprotein A-I, n = 45), 4.2% (apolipoprotein A-II, n = 39) and 5.3% (apolipoprotein B (n = 48).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148681     DOI: 10.1515/cclm.1988.26.11.685

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  12 in total

1.  Chromium picolinate inhibits cholesterol-induced stimulation of platelet aggregation in hypercholesterolemic rats.

Authors:  A A Seif
Journal:  Ir J Med Sci       Date:  2014-03-15       Impact factor: 1.568

2.  A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity.

Authors:  H Funke; A von Eckardstein; P H Pritchard; J J Albers; J J Kastelein; C Droste; G Assmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma.

Authors:  Y Huang; A von Eckardstein; S Wu; G Assmann
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.

Authors:  A von Eckardstein; H Holz; M Sandkamp; W Weng; H Funke; G Assmann
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

5.  Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations.

Authors:  J Wang; D J Freeman; S M Grundy; D M Levine; R Guerra; J C Cohen
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

6.  Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.

Authors:  A von Eckardstein; H Funke; A Henke; K Altland; A Benninghoven; G Assmann
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Electrophoretic screening for human apolipoprotein C-II variants: repeated identification of apolipoprotein C-II(K19T).

Authors:  H Wiebusch; J R Nofer; A von Eckardstein; H Funke; U Wahrburg; H Martin; E Köhler; G Assmann
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

8.  Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease.

Authors:  H Funke; A von Eckardstein; P H Pritchard; A E Hornby; H Wiebusch; C Motti; M R Hayden; C Dachet; B Jacotot; U Gerdes
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

9.  Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population.

Authors:  A von Eckardstein; H Funke; M Schulte; M Erren; H Schulte; G Assmann
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

10.  A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.

Authors:  H Funke; A von Eckardstein; P H Pritchard; M Karas; J J Albers; G Assmann
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.